Attention deficit hyperactivity disorder (ADHD). Attention-deficit hyperactivity disorder, predominantly inattentive type
Conditions
Interventions
Intervention 1: intervention group: Patients will receive 0.5 to 1 mg/kg/day methylphenidate tablet daily with Neuro feedback (third session in week) for 3 month. Intervention 2: Intervention group2:
Sponsors
Tabriz University of Medical Sciences
Eligibility
Sex/Gender
All
Age
5 Years to 14 Years
Inclusion criteria
Inclusion criteria: The ADHD according to DSM-IV-TR criteria age 5- 14 Years old consent to attend the study through the signing of informed consent
Exclusion criteria
Exclusion criteria: history of head trauma the Co-morbidity of major psychiatric disorders such as psychosis history of seizures there is a serious medical condition get medical treatment or psychological
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Hyperactivity, Inattention/ Cognition. Timepoint: Before the intervention, three months after the intervention. Method of measurement: Connor's parents questionnaire, CPT2 Test, QEEG Test. | — |
Secondary
| Measure | Time frame |
|---|---|
| Change in score of CPT-2. Timepoint: Before the intervention, three months after. Method of measurement: Continuous Performance Test (CPT-2).;Change in score (Wave) of QEEG. Timepoint: Before the intervention, three months after. Method of measurement: Quantitative Electroencephalography (QEEG).;Change in score of Conners' Parent Questionnaire. Timepoint: Before the intervention, three months after. Method of measurement: Conners' Parent Questionnaire. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDr. Noorazar
Tabriz University of Medical Sciences
Outcome results
None listed